Tracy McGregor
Vice President of Clinical Development, Chroma Medicine · Washington University/B-JH/SLCH Consortium
Credentials: · · ·
History
- 2002–2006
Doctor of Medicine
Research
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
New England Journal of Medicine · 2021 · 427 citations
Phenotype risk scores identify patients with unrecognized Mendelian disease patterns
Science · 2018 · 159 citations
American Journal of Kidney Diseases · 2016 · First of 10 authors · 105 citations
10 papers
7 papers
6 papers
5 papers
- JG
4 papers
4 papers
4 papers
4 papers
Grants
- 2012–2016
MTRNR1 Aminoglycoside Ototoxicity Outcomes and Parental Perceptions of Testing
National Institute of Child Health and Human Development · K23
Contact PI · $527.8K · Vanderbilt University
Clinical trials
- 2016–2019
Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1
Study director · Completed · Phase 1, Phase 2
Alnylam Pharmaceuticals